W Thomas Mitchell - Net Worth and Insider Trading

W Thomas Mitchell Net Worth

The estimated net worth of W Thomas Mitchell is at least $132,540 dollars as of 2024-04-18. W Thomas Mitchell is the Director of Neurocrine Biosciences Inc and owns about 1,000 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $132,540. Details can be seen in W Thomas Mitchell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that W Thomas Mitchell has not made any transactions after 2015-06-23 and currently still holds the listed stock(s).

Transaction Summary of W Thomas Mitchell

To

W Thomas Mitchell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, W Thomas Mitchell owns 1 companies in total, including Neurocrine Biosciences Inc (NBIX) .

Click here to see the complete history of W Thomas Mitchell’s form 4 insider trades.

Insider Ownership Summary of W Thomas Mitchell

Ticker Comapny Transaction Date Type of Owner
NBIX Neurocrine Biosciences Inc 2015-06-23 director

W Thomas Mitchell Latest Holdings Summary

W Thomas Mitchell currently owns a total of 1 stock. W Thomas Mitchell owns 1,000 shares of Neurocrine Biosciences Inc (NBIX) as of June 23, 2015, with a value of $132,540.

Latest Holdings of W Thomas Mitchell

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBIX Neurocrine Biosciences Inc 2015-06-23 1,000 132.54 132,540

Holding Weightings of W Thomas Mitchell


W Thomas Mitchell Form 4 Trading Tracker

According to the SEC Form 4 filings, W Thomas Mitchell has made a total of 0 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years. The most-recent trade in Neurocrine Biosciences Inc is the sale of 15,000 shares on June 23, 2015, which brought W Thomas Mitchell around $740,250.

Insider Trading History of W Thomas Mitchell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

W Thomas Mitchell Trading Performance

GuruFocus tracks the stock performance after each of W Thomas Mitchell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by W Thomas Mitchell is 10.7%. GuruFocus also compares W Thomas Mitchell's trading performance to market benchmark return within the same time period. The performance of stocks bought by W Thomas Mitchell within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how W Thomas Mitchell's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of W Thomas Mitchell

Average Return

134.9%

Average return per transaction

Outperforming Transactions

100%

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10 10.7 12.66 134.9 14.4 6.14
Relative Return to S&P 500(%) 5.66 6.08 2.06 119.63 5.68 -4.28

W Thomas Mitchell Ownership Network

Ownership Network List of W Thomas Mitchell

No Data

Ownership Network Relation of W Thomas Mitchell


W Thomas Mitchell Owned Company Details

What does Neurocrine Biosciences Inc do?

Who are the key executives at Neurocrine Biosciences Inc?

W Thomas Mitchell is the director of Neurocrine Biosciences Inc. Other key executives at Neurocrine Biosciences Inc include Chief Commerical Officer Eric Benevich , Chief Regulatory Officer Ingrid Delaet , and Chief Scientific Officer Jude Onyia .

Neurocrine Biosciences Inc (NBIX) Insider Trades Summary

Over the past 18 months, W Thomas Mitchell made no insider transaction in Neurocrine Biosciences Inc (NBIX). Other recent insider transactions involving Neurocrine Biosciences Inc (NBIX) include a net sale of 281,301 shares made by Eric Benevich , a net sale of 95,706 shares made by Darin Lippoldt , and a net sale of 75,528 shares made by Julie Cooke .

In summary, during the past 3 months, insiders sold 333,755 shares of Neurocrine Biosciences Inc (NBIX) in total and bought 0 shares, with a net sale of 333,755 shares. During the past 18 months, 1,247,725 shares of Neurocrine Biosciences Inc (NBIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,247,725 shares.

Neurocrine Biosciences Inc (NBIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Neurocrine Biosciences Inc Insider Transactions

No Available Data

W Thomas Mitchell Mailing Address

Above is the net worth, insider trading, and ownership report for W Thomas Mitchell. You might contact W Thomas Mitchell via mailing address: 48030 Paso Tiempo Ln, La Quinta Ca 92253.

Discussions on W Thomas Mitchell

No discussions yet.